Exclusive

Publication

Byline

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy Versus Physician’s Choice of Chemotherapy in Participants With B7-H4-selected Advanced/Metastatic Endometrial Cancer Who Progressed on or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More


Finance Minister outlines five pillars for Indonesia's growth

Jakarta, Oct. 26 -- Finance Minister Suahasil Nazara outlined five foundational pillars necessary to transition Indonesia into a high-income, developed nation during the Danantara Technology Innovatio... Read More


Surgery Partners To Be Acquired By HealthSpan Partners In $5.7 Bln Deal; Shares Jump

India, Oct. 26 -- Outpatient surgical facility operator Surgery Partners, Inc. (SGRY) announced on Monday that it has agreed to be acquired by HealthSpan Partners in an all-cash transaction valued at ... Read More


Govt prepares scheme for MSME involvement in free meal program

Makassar, S Sulawesi, Oct. 26 -- The Indonesian Ministry of Micro, Small, and Medium Enterprises (MSMEs) is currently formulating a scheme to involve MSMEs in supplying food ingredients for the govern... Read More


China XLX Fertiliser Ltd. Bottom Line Climbs In Nine Months

India, Oct. 26 -- China XLX Fertiliser Ltd. (1866.HK) revealed a profit for its nine months that Increased, from last year The company's earnings totaled RMB1.138 billion, or RMB0.907 per share. This... Read More


Oswal Leasing to conduct board meeting

Mumbai, Oct. 26 -- Oswal Leasing will hold a meeting of the Board of Directors of the Company on 2 November 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More


Cryogenic OGS to declare Quarterly Results

Mumbai, Oct. 26 -- Cryogenic OGS will hold a meeting of the Board of Directors of the Company on 29 October 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More